630.00GBp-2.93%Mkt Cap: 748.49M GBpP/E: —Last update: 2026-05-13
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system wh…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)48.92
PEG—
P/B8.17
P/S4.43
EV/EBITDA-43.67
EV/Revenue4.73
EPS (TTM)-0.27
EPS (Forward)0.13
Cash Flow & Leverage
FCF Yield-0.00%
FCF Margin-0.01%
Operating CF507.00K GBp
CapEx (TTM)4.76M GBp
Net Debt/EBITDA-2.81
Net Debt51.23M GBp
Technical
SMA 50607.62 (+3.7%)
SMA 200638.51 (-1.3%)
Beta1.09
S&P 52W Chg24.23%
Avg Vol (30d)266.33K
Avg Vol (10d)245.48K
Technical Indicators
RSI (14)52.8
MACD5.1875
MACD Signal0.1369
MACD Hist.+5.0506
BB Upper666.54 GBp
BB Middle620.95 GBp
BB Lower575.36 GBp
BB Width14.68%
ATR (14)33.12 GBp
Vol Ratio (20d)0.93x
52W Range
288.5051% of range962.00
52W High962.00 GBp
52W Low288.50 GBp
Profitability
Gross Margin39.10%
EBITDA Margin-10.82%
Profit Margin-17.85%
Oper. Margin-7.88%
ROE-32.98%
ROA-9.25%
Revenue Growth22.50%
Earnings Growth—
Balance Sheet
Debt/Equity1.62
Current Ratio2.20
Quick Ratio1.92
Book Value/Sh0.7560 GBp
Cash/Share0.8020 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateMay 30, 2018
Ownership
Shares Out.120.92M
Float60.81M
Insiders20.83%
Institutions55.16%
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)842.86 GBp
Target Range550.00 GBp – 1170.00 GBp
# Analysts7
Company
Market Cap748.49M GBp
Enterprise Value797.48M GBp
Revenue (TTM)168.74M GBp
Gross Profit65.98M GBp
Net Income (TTM)-30.13M GBp
Revenue/Share1.508 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees977
Last Price630.00 GBp
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINGB00BDFBVT43